F&V Capital Management’s Celgene Corp CELG Stock Holding History

F&V Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,429	Closed	-$341K	–	63
2019 Q3	$341K	Hold	3,429	–	–	0.21%	49
2019 Q2	$317K	Hold	3,429	–	–	0.19%	47
2019 Q1	$323K	Hold	3,429	–	–	0.18%	49
2018 Q4	$220K	Buy	3,429 +340	+11%	+$25.1K	0.13%	55
2018 Q3	$276K	Sell	3,089 -350	-10%	-$30.9K	0.15%	53
2018 Q2	$273K	Sell	3,439 -3,441	-50%	-$286K	0.16%	53
2018 Q1	$614K	Hold	6,880	–	–	0.34%	44
2017 Q4	$718K	Buy	6,880 +965	+16%	+$109K	0.37%	37
2017 Q3	$863K	Hold	5,915	–	–	0.5%	36
2017 Q2	$768K	Hold	5,915	–	–	0.44%	37
2017 Q1	$736K	Hold	5,915	–	–	0.43%	36
2016 Q4	$685K	Hold	5,915	–	–	0.43%	35
2016 Q3	$618K	Buy	5,915 +60	+1%	+$6.49K	0.43%	34
2016 Q2	$577K	Buy	5,855 +160	+3%	+$16.6K	0.43%	32
2016 Q1	$570K	Hold	5,695	–	–	0.45%	30
2015 Q4	$682K	Sell	5,695 -380	-6%	-$44K	0.5%	33
2015 Q3	$657K	Hold	6,075	–	–	0.47%	36
2015 Q2	$703K	Sell	6,075 -1,360	-18%	-$155K	0.48%	37
2015 Q1	$857K	Sell	7,435 -36,510	-83%	-$4.36M	0.58%	35
2014 Q4	$4.92M	Sell	43,945 -20,350	-32%	-$2.15M	3.35%	7
2014 Q3	$6.09M	Buy	64,295 +605	+0.9%	+$54.6K	4.52%	2
2014 Q2	$5.47M	Sell	63,690 -1,180	-2%	-$89.7K	4.05%	3
2014 Q1	$4.53M	Sell	64,870 -2,370	-4%	-$188K	3.58%	5
2013 Q4	$5.68M	Buy	67,240 +14,380	+27%	+$1.14M	4.53%	2
2013 Q3	$4.07M	Buy	52,860 +160	+0.3%	+$11.2K	3.45%	11
2013 Q2	$3.08M	Buy	+52,700	New	+$3.17M	2.95%	14

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

F&V Capital Management's CELG Position: Q4 2019 in Review

F&V Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,429 shares — an estimated $341K sold.

F&V Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6.09M in Q3 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

F&V Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
F&V Capital Management sold 3,429 Celgene Corp shares in Q4 2019, an estimated $341K.
F&V Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
F&V Capital Management's Celgene Corp position peaked at $6.09M in Q3 2014.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on F&V Capital Management's 13F filing for Q4 2019, filed 15 Jan 2020.